Literature DB >> 2113566

An in vitro model for cyclosporin A-induced interference of intrathymic clonal elimination.

H Kosaka1, H Matsubara, S Sogoh, M Ogata, T Hamaoka, H Fujiwara.   

Abstract

The effects of cyclosporin A (CsA) on influencing the intrathymic clonal deletion were investigated by using our established thymic stromal cell clone with capacities to express Ia antigens and to produce a unique T cell growth factor. The following were revealed: (a) T cell clone with a given specificity was killed on the Ia+ stromal cell monolayer in the presence of the relevant antigens, a process depending on T cell receptor (TCR) stimulation; and (b) CsA allowed the T cell clone to continuously proliferate even during TCR stimulation by virtue of the stromal cell-derived T cell growth factor. This paper describes an in vitro model of a mechanism by which CsA is responsible for the generation of normally "forbidden" T cell clones.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113566      PMCID: PMC2188159          DOI: 10.1084/jem.172.1.395

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  Model for clonal elimination in the thymus.

Authors:  H Kosaka; M Ogata; I Hikita; S Maruo; S Sugihara; H Matsubara; Y Takai; T Hamaoka; H Fujiwara
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

2.  T cell tolerance by clonal elimination in the thymus.

Authors:  J W Kappler; N Roehm; P Marrack
Journal:  Cell       Date:  1987-04-24       Impact factor: 41.582

Review 3.  The effects of cyclosporin A on the immune system.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

4.  Use of cyclosporin A in allogeneic bone marrow transplantation in the rat.

Authors:  P J Tutschka; W E Beschorner; A C Allison; W H Burns; G W Santos
Journal:  Nature       Date:  1979-07-12       Impact factor: 49.962

5.  Thymic stroma-derived T-cell growth factor (TSTGF): II. Biochemical and functional characterization.

Authors:  S Sato; M Ogata; H Sano; Y Mizushima; M Muramatsu; H Doi; T Itoh; T Hamaoka; H Fujiwara
Journal:  J Leukoc Biol       Date:  1988-09       Impact factor: 4.962

6.  Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes.

Authors:  P Kisielow; H Blüthmann; U D Staerz; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1988-06-23       Impact factor: 49.962

7.  Effects of cyclosporine A on T cell development and clonal deletion.

Authors:  M K Jenkins; R H Schwartz; D M Pardoll
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

8.  Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset.

Authors:  C R Stiller; J Dupré; M Gent; M R Jenner; P A Keown; A Laupacis; R Martell; N W Rodger; B von Graffenried; B M Wolfe
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

9.  The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C Bolton; G Allsopp; M L Cuzner
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  Cyclosporine-induced autoimmunity. Conditions for expressing disease, requirement for intact thymus, and potency estimates of autoimmune lymphocytes in drug-treated rats.

Authors:  R Sorokin; H Kimura; K Schroder; D H Wilson; D B Wilson
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  2 in total

1.  NADPH diaphorase-positive dendritic profiles in rat thymus are discrete from autofluorescent cells, immunoreactive for inducible nitric oxide synthase, and show strain-specific abundance differences.

Authors:  J E Downing; L Virag; I W Jones
Journal:  Immunology       Date:  1998-09       Impact factor: 7.397

2.  Demonstration of large-scale migration of cortical thymocytes to peripheral lymphoid tissues in cyclosporin A-treated rats.

Authors:  H H Zadeh; I Goldschneider
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.